A Comparison Of Cardiovascular Benefits Of Dapagliflozin And Empagliflozin In Type 2 Diabetes: A Systematic Review And Meta-analysis

Journal of Cardiac Failure 2026

View at publisher
Authors: Prutha Pathak, Aarushi Gupta, Neo Zhong Yi Benjamin, Muhammad Amayed Murtaza, Tawfiq Turjman, Anand Anghan, Namitha Salahuddin, Ashesh Das, Wajiha Syed, Chenny Koodarath, Hisham Turjman, Deng Siang Lee
+4 more Anirudh Y. Edu, Piere Tito, Muhammad Muneeb Khawar, Eisha Naveed
DOI: 10.1016/j.cardfail.2025.11.364
Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Heart Failure Treatment and Management Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Journal of Cardiac Failure
Volume
32
Issue
1
Pages
318–319
Publication date
1 January 2026
Language
EN